Advertisement

Major Ablative Procedures in the Treatment of Advanced Breast Cancer

  • A. De Schryver
Chapter
Part of the Handbuch der Medizinischen Radiologie / Encyclopedia of Medical Radiology book series (HDBRADIOL, volume 19 / 2)

Abstract

In the opinion of an increasing number of workers, major endocrine ablation now belongs to, or, at best, is slowly fading into, a — somewhat heroic — past in the history of breast cancer management. Sophisticated medical treatments based on the use of newer hormones or antihormones and combinations of cytostatic drugs have made possible truly unexpected rates of remission — unexpected, that is, until half a dozen or so years ago — and with the discovery of new and more effective drugs and combinations, it may reasonably be anticipated that still better and more lasting results may eventually come within the reach of the therapist. Nevertheless, in the opinion of this reviewer, endocrine ablative measures may, perhaps, not have lost their significance entirely.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abbes, M., Paillaud, F., Namer, M.: Réflexion à propos de 224 hypophysiolyses pour cancer du sein. In: Proc. Int. Symp. on ablative endocrine surgery in breast cancer, Lyon, 1977Google Scholar
  2. Atkins, H., Bulbrook, R.D., Falconer, M.A., Hayward, J.L., MacLean, K.S., Schurr, P.H.: Urinary steroid estimations in the prediction of response to adrenalectomy and hypophysectomy. Lancet 2, 1133–1136 (1964)PubMedCrossRefGoogle Scholar
  3. Atkins, H., Bulbrook, R.D., Falconer, M.A., Hayward, J.L., MacLean, K.S., Schurr, P.H.: Urinary steroid excretion in the prediction of response to adrenalectomy and hypophysectomy: a second clinical trial. Lancet 2, 1263–1264 (1968)Google Scholar
  4. Atkins, H.J.B., Falconer, M.A., Hayward, J.L., MacLean, K.S., Schurr, P.H.: The timing of adrenalectomy and of hypophysectomy in the treatment of advanced breast cancer. Lancet 1, 827 (1966)PubMedCrossRefGoogle Scholar
  5. Backlund, E.O., Rähn, T., Sarby, B., De Schryver, A., Wennerstrand, J.: Closed stereotaxic hypophysectomy by means of 60Co gamma radiation. Acta Radiol. [Ther.] (Stockh.) 11, 545–555 (1972)Google Scholar
  6. Bärring, N.E., Holmér, A., Notter, G., Rudén, B.I.: Interstitial irradiation of the pituitary gland with a 90Sr—90Y applicator having adjustable active length. Acta Radiol. [Ther.] (Stockh.) 8, 294–300 (1969)Google Scholar
  7. Beatson, G.T.: On the treatment of inoperable cases of carcinoma of the mamma: Suggestion for a new method of treatment, with illustrative cases. Lancet 2, 104–107; 162–165 (1896)CrossRefGoogle Scholar
  8. Bland, K.I., O’Leary, J.P., Woodward, E.R., Dragstedt, L.R.: Immediate oophorectomy and adrenalectomy in the treatment of stage III breast carcinoma. Am. J. Surg. 129, 277–285 (1975)PubMedCrossRefGoogle Scholar
  9. Bulbrook, R.D.: Tests of prediction. In: The treatment of breast cancer. Atkins, H.J.B. (ed.), pp. 177–216. Lancaster: Medical and Technical Publishing 1974Google Scholar
  10. Bulbrook, R.D.: The present position of the discriminant function in selecting patients for endocrine ablation. In: Functional explorations in senology. Colin, C., Franchimont, P., Gordenne, W., Juret, P., Lambote, R., La vigne, J., Leroux, G. F., Stoll, B.A., Vokaer, R. (eds.), pp. 237–241. Ghent: European Press 1976Google Scholar
  11. Burn, I.: Endocrine therapy — ablative surgery. In: The treatment of breast cancer. Atkins, H. (ed.), pp. 87—111. Lancaster: Medical and Technical Publishing 1974Google Scholar
  12. Buxton, P.H., Davies, F.L., Jelliffe, A.M., Jones, K.M., Logue, V., Nabarro, J.D.N., Walker, G.: Changes of pituitary function following isotope (32P) injection and pituitary stalk section. In: Endocrine aspects of breast cancer. Currie, A.R. (ed.), pp. 58–67. Edinburgh, London: Livingstone 1958Google Scholar
  13. Byron, R.L.: Bilateral adrenalectomy in advanced breast cancer. In: Major endocrine surgery for the treatment of cancer of the breast in advanced stages. Dargent, M., Romieu, Cl. (eds.), pp. 33–35. Lyon: SIMEP 1967Google Scholar
  14. Cole, M.P.: Suppression of ovarian function in primary breast cancer. In: Prognostic factors in breast cancer. Forrest, A.P.M., Kunkler, P.B. (eds.), pp. 146–156. Edinburgh, London: Livingstone 1968Google Scholar
  15. Dao, T.L.: Adrenalectomy for palliation of metastatic breast cancer. Int. J. Rad. Oncol. Biol. Phys. 4, 473–476 (1978)Google Scholar
  16. Dao, T.L., Nemoto, T., Chamberlain, A., Bross, J.: Adrenalectomy with radical mastectomy in the treatment of high-risk breast cancer. Cancer 35, 478–482 (1975)PubMedCrossRefGoogle Scholar
  17. Dunbar, H.S.: Hypophysectomy for advanced breast cancer. In: Major endocrine surgery for the treatment of cancer of the breast in advanced stages. Dargent, M., Romieu, CI. (eds.), pp. 105–107. Lyon: SIMEP 1967Google Scholar
  18. Edelstyn, G.A., MacRae, K.D.: “Early” and “late” breast cancer: A unified concept for treatment. Clin. Radiol. 27, 455–462 (1976)PubMedCrossRefGoogle Scholar
  19. Escher, F., Roth, F., Cottier, H.: Die paranasale, transethmoidosphenoidale Hypophysektomie beim metastasierenden Mammakarzinom. Schweiz. Med. Wochenschr. 88, 49–56 (1958)PubMedGoogle Scholar
  20. Forrest, A.P.M., Peebles-Brown, D.A.: Pituitary-radon implant for breast cancer. Lancet 1, 1054–1055 (1955)CrossRefGoogle Scholar
  21. Fracchia, A.A.: Indications for castration and adrenalectomy for advanced breast cancer. Cancer 28, 1699–1701 (1971)PubMedCrossRefGoogle Scholar
  22. Goldsweig, H.G., Dewys, W.D.: Steroid replacement in adrenalectomized advanced breast cancer patients receiving chemotherapy. Clin. Oncol. 3, 267–270 (1977)PubMedGoogle Scholar
  23. Hamberger, C.A., Hammer, G., Norlén, G., Sjögren, B.: Transantrosphenoidal hypophysectomy. Arch. Otolaryngol. 74, 22–28 (1961)CrossRefGoogle Scholar
  24. Hayward, J.L.: Comparison of the results of transfrontal and transphenoidal hypophysectomy. In: Proc. Int. Symp. on ablative endocrine surgery in breast cancer, Lyon, 1977Google Scholar
  25. Hayward, J.L., Atkins, H.J.B., Falconer, M.A., MacLean, K.S., Salmon, L.F.W., Schurr, P.A., Shaheen, C.H.: Clinical trials comparing transfrontal hypophysectomy with adrenalectomy and with transethmoidal hypophysectomy. In: The clinical management of advanced breast cancer. Joslin, C.A.F., Gleave, E.N. (eds.), p. 50. Cardiff: Second Tenovus Workshop 1970Google Scholar
  26. Huggins, C.: Control of cancers of man by endocrinologic methods. A review. Cancer Res. 16, 825–830 (1956)Google Scholar
  27. Huggins, C., Bergenstal, D.M.: Inhibition of human mammary and prostatic cancers by adrenalectomy. Cancer Res. 12, 134–141 (1952)PubMedGoogle Scholar
  28. Huggins, C., Scott, W.W.: Bilateral adrenalectomy in prostatic cancer. Clinical features and urinary excretion of 17-ketosteroids and estrogen. Ann. Surg. 122, 1031–1041 (1945)CrossRefGoogle Scholar
  29. Jensen, E.V., Block, G.E., Smith, S., Kyser, K., De-Sombre, E.R.: Estrogen receptors and breast cancer response to adrenalectomy. Natl. Cancer Inst. Monogr. 34, 55–70 (1971)PubMedGoogle Scholar
  30. Joint Committee on Endocrine Ablative Procedures in Disseminated Mammary Carcinoma: Adrenalectomy and hypophysectomy in disseminated mammary carcinoma. J.A.M.A. 175, 787 (1961)CrossRefGoogle Scholar
  31. Kjellberg, R.N.: Proton beam irradiation. In: Clinical endocrinology. Astwood, E.B., Cassidy, C.E. (eds.), Vol. 2, p. 103. New York: Grune & Stratton 1968Google Scholar
  32. Larsson, B., Leksell, L., Rexed, B.: The use of high energy protons for cerebral surgery in man. Acta Chir. Scand. 125, 1–12 (1963)Google Scholar
  33. Lawrence, J.H.: Heavy particle irradiation to the pituitary in metastatic breast cancer. In: Major endocrine surgery for the treatment of cancer of the breast in advanced stages. Dargent, M., Romieu, Cl. (eds.), pp. 173–174. Lyon: SIMEP 1967Google Scholar
  34. Leksell, L.: Cerebral radiosurgery. I. Gammathalamotomy in two cases of intractable pain. Acta Chir. Scand. 134, 585–595 (1968)PubMedGoogle Scholar
  35. Luft, R., Olivecrona, H.: Experiences with hypophysectomy in man. J. Neurosurg. 10, 301–316 (1953)PubMedCrossRefGoogle Scholar
  36. Luft, R., Olivecrona, H., Sjögren, B.: Hypophysektomi på människa. Nord, Med. 47, 351–354 (1952)Google Scholar
  37. Luft, R., Olivecrona, H., Ikkos, D., Nilsson, L.B., Mossberg, H.: Hypophysectomy in the management of metastatic carcinoma of the breast. In: Endocrine aspects of breast cancer. Currie, A.R. (ed.), pp. 27–35. Edinburgh, London: Livingstone 1958Google Scholar
  38. Mayer, M., Dargent, M., Pommatau, E., Saez, S.: Résultats de la transplantation surréno-splénique associée à la surrénalectomie droite et à l’ovariectomie. In: Major endocrine surgery for the treatment of cancer of the breast in advanced stages. Dargent, M., Romieu, Cl. (eds.), pp. 67–73. Lyon: SIMEP 1967Google Scholar
  39. Mayer, M., Colon, J., Brunat, M., Saez, S., Pommatau, E.: Clinical results of endocrine ablative surgery in breast cancer. In: Proc. Int. Symp. on ablative endocrine surgery in breast cancer, Lyon, 1977Google Scholar
  40. McFadyen, I.J., Raag, G., Buchan, R., Forrest, A.P.M., Golder, M.P., Groom, G.V., Griffiths, K.: Pituitary function and clinical response in breast cancer patients after yttrium implantation. Clin. Oncol. 5, 33–41 (1979)PubMedGoogle Scholar
  41. McGuire, W.L.: Estrogen receptors in human breast cancer. J. Clin. Invest. 52, 73–77 (1973)PubMedCrossRefGoogle Scholar
  42. McGuire, W.L., Horwitz, K.B. De La Garza, M.: Selecting endocrine therapy in breast cancer. In: Steroid hormone action and cancer. Menon, K.M.J., Reel, J.R. (eds.), pp. 28–35. New York, London: Plenum 1976Google Scholar
  43. McGuire, W.L., Horwitz, K.B., Pearson, O.H., Segaloff, A.: Current status of estrogen and progesterone receptor in breast cancer. Cancer 39, 2934–2947 (1977)PubMedCrossRefGoogle Scholar
  44. Meakin, J.W., Allt, W.E.C., Beale, F.A., Brown, T.C., Bush, R.S.: Clark, R.M., Fitzpatrick, P.J., Hawkins, N.V., Jenkin, R.D.T., Pringle, J.F., Rider, W.D.: Ovarian irradiation and prednisone following surgery for carcinoma of the breast. In: Adjuvant therapy of cancer. Salmon, S.S., Jones, S.E. (eds.), pp. 95–99. Amsterdam, Oxford, New York: North-Holland 1977Google Scholar
  45. Minton, J.P.: The response of breast cancer patients with bone pain to L-dopa. Cancer 33, 358–363 (1974)PubMedCrossRefGoogle Scholar
  46. Minton, J.P.: Precise selection of breast cancer patients with bone metastasis for endocrine ablation. Surgery 80, 513–517 (1976)PubMedGoogle Scholar
  47. Mundinger, F., Riechert, T.: Hypophysentumoren und Hypophysektomie. pp. 210–259. Stuttgart: Thieme 1967Google Scholar
  48. Nissen-Meyer, R.: Suppression of ovarian function in primary breast cancer. In: Prognostic factors in breast cancer. Forrest, A.P.M., Kunkler, P.B. (eds.), pp. 139–145. Edinburgh, London: Livingstone 1968Google Scholar
  49. Notter, G.: A technique for destruction of the hypophysis using Y90-spheres. Acta Radiol. [Suppl.] (Stockh.) 184(1959)Google Scholar
  50. Notter, G., Melander, O.: Pituitary implantation with 90-Yttrium in the treatment of advanced breast cancer. In: Major endocrine surgery for the treatment of cancer of the breast in advanced stages. Dargent, M., Romieu, Cl. (eds.), pp. 113–121. Lyon: SIMEP 1967Google Scholar
  51. Patey, D.H., Nabarro, J.D.: Early (“prophylactic”) oophorectomy and adrenalectomy in carcinoma of the breast. A ten-year follow-up. Br. J. Cancer 24, 16–21 (1970)Google Scholar
  52. Perrault, M., Le Beau, J., Klotz, B., Sicard, J., Clavel, B.: L’hypophysectomie totale dans le traitement du cancer du sein. Premier cas français. Avenir de la méthode. Therapie 7, 290–301 (1952)PubMedGoogle Scholar
  53. Rasmussen, T.B., Harper, P.V., Kennedy, T.: Use of beta ray point sources for destruction of the hypophysis. Surg. Forum 4, 681–686 (1953)PubMedGoogle Scholar
  54. Robin, P.E., Dalton, G.A.: The role of major endocrine ablation. In: Breast cancer management — early and late. Stoll, B.A. (ed.), pp. 147–156. London: Heinemann 1977Google Scholar
  55. Saez-Poulain, S., Pommatau, E., Dargent, M., Mayer, M.: Valeur fonctionelle de la transplantation surréno-splénique dans le cancer du sein en phase avancée chez la femme. Ann. Endocrinol (Paris) 26, 393–108 (1965)Google Scholar
  56. Scheer, K.-E.: Technique and results of radioactive pituitary implantations in cases of advanced breast carcinoma. In: Major endocrine surgery for the treatment of cancer of the breast in advanced stages. Dargent, M., Romieu, Cl. (eds.). pp. 93–95. Lyon: SIMEP 1967Google Scholar
  57. Schinzinger, A.: Über Carcinoma Mammae. Vortr. Dtsch. Ges. Chir. XVIII. Kongr. Berlin, 1889, pp. 28–29.Google Scholar
  58. Schmidt, M.L., Nemoto, T., Dao, T., Bross, I.D.J.: Prognostic factors affecting adrenalectomy in patients with metastatic cancer of the breast. Cancer 27, 1106–1111 (1971)PubMedCrossRefGoogle Scholar
  59. Shimkin, M.B., Boldvey, E.B., Kelly, K.H., Bierman, H.R., Ortega, P., Nattziger, H.C.: Effects of surgical hypophysectomy in a man with malignant melanoma. J. Clin. Endocrinol. 12, 439–453 (1952)CrossRefGoogle Scholar
  60. Smets, W., Dor, P., Verschure, J.: La chirurgie endocrinienne dans le cancer du sein en phase avancée. Techniques et résultats de la chirurgie surrénalienne. In: Major endocrine surgery for the treatment of cancer of the breast in advanced stages. Dargent, M., Romieu, Cl. (eds.), pp. 15–21. Lyon: SIMEP 1967Google Scholar
  61. Stewart, H.J.: In: The clinical management of advanced breast cancer. Joslin, C.A.F., Gleave, E.N. (eds.), p. 73. Cardiff: Second Tenovus Workshop 1970Google Scholar
  62. Tobias, C.A., Lawrence, J.H., Born, J.L., McCombs, R.K., Roberts, J.E., Anger, H.O., Low-Beer, B.V.A., Huggins, C.B.: Pituitary irradiation with high energy proton beams. A preliminary report. Cancer Res. 18, 121–134 (1958)PubMedGoogle Scholar
  63. Westbury, G.: Adrenalectomy for breast cancer. Technique and results. In: Major endocrine surgery for the treatment of cancer of the breast in advanced stages. Dargent, M., Romieu, Cl. (eds.), pp. 31–32. Lyon: SIMEP 1967Google Scholar
  64. Young, S.: Pituitary necrosis due to implants of radioactive gold and yttrium. Lancet 1, 548–551 (1957)CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1982

Authors and Affiliations

  • A. De Schryver

There are no affiliations available

Personalised recommendations